New hope for ovarian cancer: experimental drug plus chemo enters phase 3 trial
NCT ID NCT06915025
First seen Oct 31, 2025 · Last updated Apr 28, 2026 · Updated 27 times
Summary
This phase 3 trial tests whether adding the experimental drug IMNN-001 to standard chemotherapy helps people with advanced ovarian, fallopian tube, or primary peritoneal cancer live longer. About 500 newly diagnosed adults will receive either chemo alone or chemo plus IMNN-001, given into the abdomen. The study is currently recruiting.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OVARIAN CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Advent Health
RECRUITINGOrlando, Florida, 32804, United States
Contact Email: •••••@•••••
Contact
-
Erlanger Health
RECRUITINGChattanooga, Tennessee, 37403, United States
Contact Email: •••••@•••••
Contact Email: •••••@•••••
Contact
-
Froedtert and The Medical College of Wisconsin
RECRUITINGMilwaukee, Wisconsin, 53226, United States
Contact Email: •••••@•••••
Contact
-
Providence Cancer Institute
RECRUITINGPortland, Oregon, 97213, United States
Contact
Contact Email: •••••@•••••
-
Providence Sacred Heart Medical Center & Children's Hospital
RECRUITINGSpokane, Washington, 99204, United States
Contact Email: •••••@•••••
Contact
-
Sanford Health
RECRUITINGSioux Falls, South Dakota, 57104, United States
Contact Email: •••••@•••••
Contact
-
Washington University School of Medicine in St. Louis
RECRUITINGSt Louis, Missouri, 63110, United States
Contact
Contact Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.